Thomson Reuters Reports Second-Quarter 2026 Results

Thomson Reuters reported Q2 revenue of $1.954B (+9% YoY) and diluted EPS of $1.02 (+48%), driven by 8% organic revenue growth (+10% in the “Big 3” segments). The company raised its FY2026 growth outlook to ~8.0% total organic growth and 9.5%–10.0% for the “Big 3,” while also completing shareholder returns (a $605M return of capital and a $600M buyback) and repaying $500M of 3.35% notes. It signed a definitive agreement with KKR to form a JV for its Global Print business, with Thomson Reuters selling a 51% stake for approximately $500M in gross proceeds (expected Q4 2026 close), alongside continued investment momentum in “fiduciary-grade” AI solutions.

Analysis

TRI is behaving less like a mature information vendor and more like a self-funding software compounder: the mix shift toward recurring workflows plus AI add-ons should support a higher multiple if management can prove that premium pricing is retention-led rather than one-time upsell. The market should focus on FCF durability and share count reduction, because the combination of buybacks, special distributions, and asset pruning mechanically lifts per-share economics even if top-line growth normalizes.

The Global Print separation is strategically important mainly as a margin and narrative clean-up. Removing the low-growth drag should sharpen reported organic growth and simplify the sum-of-parts story, but the bigger second-order effect is competitive: it forces peers like RELX/LSEGY to defend legal and tax wallet-share against a better-capitalized TRI that is reallocating cash into AI product development and distribution. If CoCounsel / Thomson LLM adoption is real, this is the kind of product cycle that can pull forward share gains over 6-18 months, not just improve next quarter.

KKR is the obvious financial buyer, but the structure reads more like a cash-yielding carved-out asset with downside protection than a clean growth acquisition, so upside there is limited unless the royalty/transition economics are richer than disclosed. The main contrarian risk is that investors may be extrapolating a few quarters of easy comp and capital returns into a durable re-rating; if organic growth slips back toward mid-single digits or AI monetization stalls, the multiple can compress quickly despite the cleaner portfolio. Regulatory timing for the JV and any evidence of print deterioration faster than modeled are the key falsifiers over the next 1-3 months.

Key Decisions for Investors

• Long TRI on post-print spin/JV-related weakness; prefer a 1-3 month entry window if the stock fades on execution skepticism. Risk/reward is favorable as long as organic growth holds near the raised range and capital return stays on pace; exit if management reverts to single-digit growth without margin leverage.
• Use TRI as a quality-growth vs. legacy data compounding vehicle in the software bucket; if you need a relative-value expression, pair TRI long against a basket of slower-growing content/data names that lack visible AI monetization, with the thesis that TRI deserves a premium for self-help and buybacks.
• Treat KKR as an event-driven, not strategic, long only if the implied economics on the JV look mispriced after the definitive agreement details are digested. Otherwise, do not force it: the structure appears more utility-like than venture-like, limiting upside.
• Watch for a failed AI monetization narrative: if next quarter does not show incremental pricing/seat expansion from CoCounsel and the LLM rollout, fade strength in TRI and trim into any multiple expansion above the recent re-rating band.
• No clean hedge is obvious from the provided tickers; if you want downside protection, use the options market on TRI rather than a weak equity pair.